ARCHIVES

NCI Spent $381.2 Million On PR From 2006 to 2012, Vastly Outspending Other NIH, FDA Units

This article is from The Cancer Letter archive.

Vol. 39 No. 09 | March 1, 2013

Download PDF Visit The Full Archive

Related Articles

Funding Opportunities: Aging Institute Offers Program Announcement

February 6, 1998

Successful Treatment by Community MDs Reducing Numbers Of Patients In Research, DCT Board Told; “We can Work With them,” Carbone Says

April 27, 1979

IOM Panel: NCI Clinical Trials Groups At “Breaking Point,” More Funds Needed.

April 16, 2010

NCI Begins TAILORx Study.

May 26, 2006

Zevalin Regimen Effective In Mantle Cell Lymphoma

January 30, 2004

Also in this 12-page issue: NCI’s Lance Liotta and FDA’s Emanuel Petricoin to move to George Mason University.

March 11, 2005